| __timestamp | Dr. Reddy's Laboratories Limited | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 16606000 |
| Thursday, January 1, 2015 | 62786000000 | 21497000 |
| Friday, January 1, 2016 | 62427000000 | 25462000 |
| Sunday, January 1, 2017 | 62453000000 | 28195000 |
| Monday, January 1, 2018 | 65724000000 | 33078000 |
| Tuesday, January 1, 2019 | 70421000000 | 36523000 |
| Wednesday, January 1, 2020 | 80591000000 | 41455000 |
| Friday, January 1, 2021 | 86645000000 | 74400000 |
| Saturday, January 1, 2022 | 100551000000 | 101582000 |
| Sunday, January 1, 2023 | 42907000000 | 112903000 |
| Monday, January 1, 2024 | 115557000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical and biotechnology sectors, understanding cost structures is crucial. Dr. Reddy's Laboratories Limited, a global pharmaceutical giant, and Veracyte, Inc., a leading genomic diagnostics company, offer intriguing insights into cost management over the past decade.
From 2014 to 2023, Dr. Reddy's Laboratories saw a significant fluctuation in its cost of revenue. The company experienced a 105% increase from 2014 to 2024, peaking in 2024. However, 2023 marked a notable dip, with costs dropping by over 57% compared to the previous year.
Veracyte, Inc. demonstrated a steady upward trend, with costs rising by approximately 580% from 2014 to 2023. This growth reflects the company's expanding operations and market reach.
The data highlights the dynamic nature of cost management in these industries, with Dr. Reddy's showing more volatility compared to Veracyte's consistent growth.
Comparing Cost of Revenue Efficiency: Pfizer Inc. vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: United Therapeutics Corporation vs Veracyte, Inc.
Analyzing Cost of Revenue: Viatris Inc. and Veracyte, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Veracyte, Inc.
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Xencor, Inc.
Dr. Reddy's Laboratories Limited vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Veracyte, Inc. vs HUTCHMED (China) Limited
Analyzing Cost of Revenue: Veracyte, Inc. and Ligand Pharmaceuticals Incorporated
Cost Insights: Breaking Down Veracyte, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Veracyte, Inc. and Geron Corporation's Expenses